Advertisement

Ads Placeholder
Loading...

Qiagen N.V.

QGEN•NYSE
Healthcare
Medical - Diagnostics & Research
$41.03
$0.65(1.61%)
U.S. Market opens in 21h 55m

Qiagen N.V. (QGEN) Stock Overview

Explore Qiagen N.V.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap8.5B
P/E Ratio20.06
EPS (TTM)$2.04
ROE0.12%
Fundamental Analysis

AI Price Forecasts

1 Month$44.90
3 Months$50.63
1 Year Target$49.23

QGEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Qiagen N.V. (QGEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.32, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $49.23.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 20.06 and a market capitalization of 8.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.61%
5-Day Change
3.14%
1-Month Change
-13.89%
3-Month Change
-13.75%
6-Month Change
-12.33%
Year-to-Date (YTD) Change
-13.75%
1-Year Change
1.63%
3-Year Change
-10.51%
5-Year Change
-17.97%
All-Time (Max) Change
1972.22%

Contact Information

https://www.qiagen.com
31 77 355 6600
Hulsterweg 82, Venlo, NaN, 5912 PL

Company Facts

57,000 Employees
IPO DateJun 28, 1996
CountryNL
Actively Trading

Frequently Asked Questions